Adverse childhood experiences predict opioid relapse during treatment among rural adults

Karen Derefinko, Francisco I. Salgado García, Kevin M. Talley, Zoran Bursac, Karen Johnson, James G. Murphy, Meghan E. McDevitt-Murphy, Frank Andrasik, Daniel D. Sumrok

Research output: Contribution to journalArticle

Abstract

Adverse childhood experiences (ACE) are a public health concern and strong predictor of substance abuse, but no studies to date have explored the association between ACE and opioid relapse during medication-assisted treatment. Using an observational design, we examined this relationship using archived medical records of 87 patients who attended opioid use disorder treatment (buprenorphine-naloxone and group counseling) at a rural medical clinic. All variables were collected from medical files. ACE scores were derived from a 10-item screening questionnaire administered at intake, a regular procedure for this clinic. The primary outcome was opioid relapse observed at each visit, as indicated by self-reported opioid use, positive urine drug screen for opioids, or prescription drug database results for opioid acquisition. The sample was 100% Caucasian and 75% male. A total of 2052 visit observations from the 87 patients were extracted from the medical records. Patients had an average of 23.6 (SD = 22) treatment visits. Opioid relapse occurred in 54% of patients. Results indicated that for every unit increase in ACE score, there was an increase of 17% in the odds of relapse (95% CI: 1.05–1.30, p = .005). Additionally, each treatment visit was associated with a 2% reduction in the odds of opioid relapse (95% CI: 0.97–0.99, p = .008). We conclude that ACE may increase the risk for poor response to buprenorphine-naloxone treatment due to high rates of opioid relapse during the first treatment visits. However, consistent adherence to treatment is likely to reduce the odds of opioid relapse.

Original languageEnglish (US)
Pages (from-to)171-174
Number of pages4
JournalAddictive Behaviors
Volume96
DOIs
StatePublished - Sep 1 2019

Fingerprint

Opioid Analgesics
Recurrence
Therapeutics
Medical Records
Pharmaceutical Databases
Prescription Drugs
Public health
Substance-Related Disorders
Counseling
Screening
Public Health
Association reactions
Urine
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Clinical Psychology
  • Toxicology
  • Psychiatry and Mental health

Cite this

Adverse childhood experiences predict opioid relapse during treatment among rural adults. / Derefinko, Karen; Salgado García, Francisco I.; Talley, Kevin M.; Bursac, Zoran; Johnson, Karen; Murphy, James G.; McDevitt-Murphy, Meghan E.; Andrasik, Frank; Sumrok, Daniel D.

In: Addictive Behaviors, Vol. 96, 01.09.2019, p. 171-174.

Research output: Contribution to journalArticle

Derefinko, K, Salgado García, FI, Talley, KM, Bursac, Z, Johnson, K, Murphy, JG, McDevitt-Murphy, ME, Andrasik, F & Sumrok, DD 2019, 'Adverse childhood experiences predict opioid relapse during treatment among rural adults', Addictive Behaviors, vol. 96, pp. 171-174. https://doi.org/10.1016/j.addbeh.2019.05.008
Derefinko, Karen ; Salgado García, Francisco I. ; Talley, Kevin M. ; Bursac, Zoran ; Johnson, Karen ; Murphy, James G. ; McDevitt-Murphy, Meghan E. ; Andrasik, Frank ; Sumrok, Daniel D. / Adverse childhood experiences predict opioid relapse during treatment among rural adults. In: Addictive Behaviors. 2019 ; Vol. 96. pp. 171-174.
@article{b22f4f932fab4a97ae2b8ef7b6a9c294,
title = "Adverse childhood experiences predict opioid relapse during treatment among rural adults",
abstract = "Adverse childhood experiences (ACE) are a public health concern and strong predictor of substance abuse, but no studies to date have explored the association between ACE and opioid relapse during medication-assisted treatment. Using an observational design, we examined this relationship using archived medical records of 87 patients who attended opioid use disorder treatment (buprenorphine-naloxone and group counseling) at a rural medical clinic. All variables were collected from medical files. ACE scores were derived from a 10-item screening questionnaire administered at intake, a regular procedure for this clinic. The primary outcome was opioid relapse observed at each visit, as indicated by self-reported opioid use, positive urine drug screen for opioids, or prescription drug database results for opioid acquisition. The sample was 100{\%} Caucasian and 75{\%} male. A total of 2052 visit observations from the 87 patients were extracted from the medical records. Patients had an average of 23.6 (SD = 22) treatment visits. Opioid relapse occurred in 54{\%} of patients. Results indicated that for every unit increase in ACE score, there was an increase of 17{\%} in the odds of relapse (95{\%} CI: 1.05–1.30, p = .005). Additionally, each treatment visit was associated with a 2{\%} reduction in the odds of opioid relapse (95{\%} CI: 0.97–0.99, p = .008). We conclude that ACE may increase the risk for poor response to buprenorphine-naloxone treatment due to high rates of opioid relapse during the first treatment visits. However, consistent adherence to treatment is likely to reduce the odds of opioid relapse.",
author = "Karen Derefinko and {Salgado Garc{\'i}a}, {Francisco I.} and Talley, {Kevin M.} and Zoran Bursac and Karen Johnson and Murphy, {James G.} and McDevitt-Murphy, {Meghan E.} and Frank Andrasik and Sumrok, {Daniel D.}",
year = "2019",
month = "9",
day = "1",
doi = "10.1016/j.addbeh.2019.05.008",
language = "English (US)",
volume = "96",
pages = "171--174",
journal = "Addictive Behaviors",
issn = "0306-4603",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Adverse childhood experiences predict opioid relapse during treatment among rural adults

AU - Derefinko, Karen

AU - Salgado García, Francisco I.

AU - Talley, Kevin M.

AU - Bursac, Zoran

AU - Johnson, Karen

AU - Murphy, James G.

AU - McDevitt-Murphy, Meghan E.

AU - Andrasik, Frank

AU - Sumrok, Daniel D.

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Adverse childhood experiences (ACE) are a public health concern and strong predictor of substance abuse, but no studies to date have explored the association between ACE and opioid relapse during medication-assisted treatment. Using an observational design, we examined this relationship using archived medical records of 87 patients who attended opioid use disorder treatment (buprenorphine-naloxone and group counseling) at a rural medical clinic. All variables were collected from medical files. ACE scores were derived from a 10-item screening questionnaire administered at intake, a regular procedure for this clinic. The primary outcome was opioid relapse observed at each visit, as indicated by self-reported opioid use, positive urine drug screen for opioids, or prescription drug database results for opioid acquisition. The sample was 100% Caucasian and 75% male. A total of 2052 visit observations from the 87 patients were extracted from the medical records. Patients had an average of 23.6 (SD = 22) treatment visits. Opioid relapse occurred in 54% of patients. Results indicated that for every unit increase in ACE score, there was an increase of 17% in the odds of relapse (95% CI: 1.05–1.30, p = .005). Additionally, each treatment visit was associated with a 2% reduction in the odds of opioid relapse (95% CI: 0.97–0.99, p = .008). We conclude that ACE may increase the risk for poor response to buprenorphine-naloxone treatment due to high rates of opioid relapse during the first treatment visits. However, consistent adherence to treatment is likely to reduce the odds of opioid relapse.

AB - Adverse childhood experiences (ACE) are a public health concern and strong predictor of substance abuse, but no studies to date have explored the association between ACE and opioid relapse during medication-assisted treatment. Using an observational design, we examined this relationship using archived medical records of 87 patients who attended opioid use disorder treatment (buprenorphine-naloxone and group counseling) at a rural medical clinic. All variables were collected from medical files. ACE scores were derived from a 10-item screening questionnaire administered at intake, a regular procedure for this clinic. The primary outcome was opioid relapse observed at each visit, as indicated by self-reported opioid use, positive urine drug screen for opioids, or prescription drug database results for opioid acquisition. The sample was 100% Caucasian and 75% male. A total of 2052 visit observations from the 87 patients were extracted from the medical records. Patients had an average of 23.6 (SD = 22) treatment visits. Opioid relapse occurred in 54% of patients. Results indicated that for every unit increase in ACE score, there was an increase of 17% in the odds of relapse (95% CI: 1.05–1.30, p = .005). Additionally, each treatment visit was associated with a 2% reduction in the odds of opioid relapse (95% CI: 0.97–0.99, p = .008). We conclude that ACE may increase the risk for poor response to buprenorphine-naloxone treatment due to high rates of opioid relapse during the first treatment visits. However, consistent adherence to treatment is likely to reduce the odds of opioid relapse.

UR - http://www.scopus.com/inward/record.url?scp=85065565513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065565513&partnerID=8YFLogxK

U2 - 10.1016/j.addbeh.2019.05.008

DO - 10.1016/j.addbeh.2019.05.008

M3 - Article

VL - 96

SP - 171

EP - 174

JO - Addictive Behaviors

JF - Addictive Behaviors

SN - 0306-4603

ER -